Kojic acid and hydroquinone are often compared as if they are two versions of the same brightening product.
That frame is too loose for melasma after menopause.
Hydroquinone sits in a prescription and regulatory lane in the United States. Kojic acid usually sits in an alternative or adjunct ingredient lane. Both can irritate skin. Neither should be used to diagnose a brown patch.
Bottom line
Hydroquinone has the stronger prescription-regulated melasma lane. Kojic acid may be useful as a non-hydroquinone ingredient or as part of a combination plan, but the direct evidence is smaller and older.
The safer decision starts with diagnosis, strict light protection, product source, irritation risk, skin tone and post-inflammatory hyperpigmentation risk, pregnancy or breastfeeding context, and a stop or maintenance plan.
Quick comparison
| Question | Kojic acid | Hydroquinone |
|---|---|---|
| Main role in melasma care | Alternative or adjunct pigment ingredient; often found in combination products. | Common prescription pigment treatment; also part of triple-combination melasma cream. [1] [2] |
| Evidence strength | Some small studies and review-level evidence, but less direct certainty than hydroquinone-based regimens. [3] [4] [5] | Stronger treatment history and more formal prescription framing, especially in hydroquinone-containing combinations. [1] [6] |
| Irritation risk | Can sting, redden, peel, or irritate; one split-face study found more irritation than the hydroquinone side. [3] | Can irritate and carries specific monitoring issues such as ochronosis and uneven lightening when used incorrectly or too long. [1] |
| Product-source issue | Cosmetic products vary in strength, formulation, and quality. | U.S. Food and Drug Administration says there are no legally marketed over-the-counter skin-lightening drug products; prescription source matters. [1] |
| Best fit | Someone with confirmed melasma who needs a non-hydroquinone or adjunct plan and can monitor irritation. | Someone with confirmed melasma whose clinician thinks a prescription course fits the diagnosis, skin type, and risk profile. |
The choice is not "natural ingredient versus prescription ingredient." It is a fit question.
First, make sure the dark patch is melasma
American Academy of Dermatology says a dermatologist can often diagnose melasma by looking closely at the face and neck. A Wood's lamp or dermatoscope can help assess pigment depth, and biopsy may be used when melasma could be another skin condition. [2]
That matters after menopause because facial pigment can be melasma, lentigines, sun damage, post-inflammatory hyperpigmentation, medication pigment, seborrheic keratoses, actinic keratoses, or a lesion that needs direct examination.
| Pattern | Why it changes the plan |
|---|---|
| Symmetric brown-gray patches on cheeks, forehead, upper lip, or jawline | Can fit melasma, but triggers, pigment depth, and skin tone still shape treatment. |
| Dark marks after acne, rash, laser, peel, burn, or irritation | May be post-inflammatory hyperpigmentation; irritating treatment can worsen pigment. |
| Rough, scaly, bleeding, painful, changing, or one-sided spot | Needs skin examination before pigment treatment. |
| Brown patches plus facial flushing, burning, or visible vessels | Rosacea and irritation can overlap with pigment plans. |
| Pigment worsening after imported, online, or unlabeled lightening products | Product-source, steroid, mercury, hydroquinone, allergy, or ochronosis concerns need review. |
The first step is not choosing the ingredient. It is naming the condition.
What the current safety frame says about hydroquinone
The U.S. Food and Drug Administration says there are no legally marketed over-the-counter skin-lightening drug products. It also says TRI-LUMA is currently the only FDA-approved drug containing hydroquinone, and that TRI-LUMA is prescription-only. [1]
That does not mean every hydroquinone discussion is bad. It means hydroquinone should be treated as prescription pigment care, not casual shelf care.
U.S. Food and Drug Administration also says it has received reports of serious side effects from products containing hydroquinone, including skin rashes, facial swelling, and ochronosis, a skin discoloration. [1]
This is why product source matters. A labeled prescription, a compounded cream, and an imported or unapproved lightening product are not the same decision.
Related reading:
- Hydroquinone and TRI-LUMA for Melasma After Menopause.
- Melasma After Menopause Treatment Options.
- Tranexamic Acid for Melasma After Menopause.
What the kojic acid evidence shows
The most directly relevant head-to-head evidence is old and small.
In a 39-patient split-face study, patients used glycolic acid plus kojic acid on one side of the face and a similar glycolic acid plus hydroquinone formulation on the other side. Fifty-one percent responded equally to both sides, 28% had a more dramatic reduction on the kojic acid side, and 21% had a more dramatic improvement with hydroquinone. The results were not statistically different, and the kojic acid preparation was more irritating. [3]
Another split-face study treated 40 Chinese women with epidermal melasma. One side received 2% kojic acid in a gel containing 10% glycolic acid and 2% hydroquinone; the other side received the same gel without kojic acid. More than half of melasma cleared in 24 of 40 patients, or 60%, on the kojic acid side, compared with 19 of 40, or 47.5%, on the side without kojic acid. Redness, stinging, and exfoliation occurred on both sides and settled by the third week. [4]
Those studies support a modest point: kojic acid can be part of a melasma regimen. They do not prove kojic acid is generally superior, gentler for every skin type, or strong enough to replace diagnosis and prescription review.
What broader reviews add
A 2022 systematic review and meta-analysis evaluated topical agents for melasma. It included 45 studies with 2,359 patients for efficacy and 55 studies with 4,539 patients for adverse effects. Hydroquinone monotherapy, hydroquinone-containing combination therapy, cysteamine, tranexamic acid, azelaic acid, and kojic acid all showed improvement signals, while zinc sulfate did not show statistically significant improvement. The review reported irritation incidence of 50.9% for hydroquinone-containing combination therapy and 5.3% for kojic acid, but concluded treatment should be guided by patient tolerance, availability, and physician experience. [5]
A Cochrane review of 20 melasma studies with 2,125 participants found triple-combination cream was more effective at lightening melasma than hydroquinone alone, but also described available treatments as unsatisfactory and the evidence as heterogeneous. [6]
The practical takeaway is not that one ingredient wins. It is that melasma treatment is staged: diagnosis, light protection, topical fit, irritation tolerance, prescription boundaries, and maintenance.
Why menopause changes the conversation
Menopause does not make kojic acid or hydroquinone automatically better or worse.
It changes the surrounding context. Many women after menopause are managing cumulative sun exposure, thinner or drier skin, rosacea, adult acne, retinoid tolerance, procedures, medication changes, and a higher chance that a "brown spot" could be sun damage rather than melasma.
| Midlife factor | Why it matters |
|---|---|
| Drier or more reactive skin | Irritating actives can cause peeling, burning, and post-inflammatory hyperpigmentation. |
| Years of ultraviolet and visible-light exposure | Lentigines and actinic damage may coexist with melasma. |
| Prior peels, lasers, retinoids, or acne treatments | Barrier status and pigment history change the sequence. |
| Darker skin tone or history of pigment after irritation | Procedures and strong actives need careful staging. |
| Pregnancy, breastfeeding, or hormone history still relevant | Product labels and clinician guidance may change ingredient selection. |
| Imported or online lightening products | Ingredient uncertainty and illegal skin-lightening products can raise risk. [1] |
For women in midlife and after menopause, the useful question is: which pigment lane are we in, and what is the least irritating plan that can still work?
Who each option may fit
| Situation | More likely discussion |
|---|---|
| Confirmed moderate or persistent melasma, clear prescription plan, reliable sunscreen use | Hydroquinone or triple-combination therapy may be discussed. |
| Hydroquinone not preferred, not tolerated, not appropriate, or not needed yet | Kojic acid, azelaic acid, vitamin C, retinoid, or sunscreen-first care may be considered. [2] |
| Stubborn melasma already using sunscreen and topicals | Dermatology may discuss tranexamic acid, peels, microneedling, laser, or light procedures with pigment-risk counseling. [2] |
| Pigment is new, changing, rough, bleeding, painful, or one-sided | Dermatology examination before lightening treatment. |
| Irritation, burning, or peeling is already active | Repair barrier and reassess before adding stronger pigment actives. |
Kojic acid may be appealing because it sounds less medical. Hydroquinone may be appealing because it sounds stronger. Neither shortcut is enough.
Red flags before pigment treatment
American Academy of Dermatology teaches the ABCDE warning signs for melanoma: asymmetry, border irregularity, color variation, diameter larger than a pencil eraser, or evolution in size, shape, or color. [7]
For a melasma search, the practical red flags are broader:
| Red flag | Better action |
|---|---|
| A spot is changing, bleeding, painful, ulcerated, rough, scaly, or not healing | Have it checked before treating pigment. |
| Pigment appeared after a burn, peel, laser, rash, or severe irritation | Treat the barrier and diagnosis before adding more irritants. |
| Darkening becomes blue-black or gray-black during hydroquinone use | Stop and contact the prescriber because ochronosis is a known concern. [1] |
| The product is unlabeled, imported, bought through social media, or has unclear ingredients | Do not treat availability as safety; review the product with a clinician. |
| A prescription-strength or compounded pigment cream is being considered | Review ingredients, concentration, dosing, duration, pregnancy or breastfeeding context, and stop rules. |
What to ask a clinician
Ask:
- Is this definitely melasma, or could it be lentigines, post-inflammatory hyperpigmentation, medication pigment, actinic damage, or another diagnosis?
- Does my skin type or history of post-inflammatory hyperpigmentation make irritation a bigger risk?
- Should I start with tinted broad-spectrum sunscreen, barrier repair, and trigger control before any active ingredient?
- If hydroquinone is considered, what is the source, concentration, duration, stop rule, and maintenance plan?
- If kojic acid is considered, is it being used alone, with hydroquinone, with glycolic acid, or with another active, and how will irritation be monitored?
- Are pregnancy, breastfeeding, hormone history, retinoid use, rosacea, eczema, procedures, or current medicines relevant to the plan?
- What should improve by 8 to 12 weeks, and what means the plan should stop or change?
What to do next
Kojic acid vs hydroquinone should be a diagnosis-first pigment decision.
Hydroquinone has the stronger prescription-regulated lane. Kojic acid can be a reasonable alternative or adjunct, but its head-to-head evidence is small and it can irritate skin. For melasma after menopause, the best plan starts with confirming the diagnosis, using daily light protection, checking product source, matching treatment intensity to irritation risk, and setting a stop or maintenance rule.
Related reading:
- Azelaic Acid After Menopause.
- Laser for Melasma After Menopause.
- Tinted Sunscreen for Melasma After Menopause.
References
[1] U.S. Food and Drug Administration. Skin Facts! What You Need to Know About Skin Lightening Products. https://www.fda.gov/consumers/health-fraud-scams/skin-facts-what-you-need-know-about-skin-lightening-products
[2] American Academy of Dermatology. Melasma: Diagnosis and treatment. https://www.aad.org/public/diseases/a-z/melasma-treatment
[3] Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22(5):443-7. doi:10.1111/j.1524-4725.1996.tb00345.x https://pubmed.ncbi.nlm.nih.gov/8634807/
[4] Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 1999;25(4):282-4. doi:10.1046/j.1524-4725.1999.08236.x https://pubmed.ncbi.nlm.nih.gov/10417583/
[5] Chang YF, Lee TL, Oyerinde O, et al. Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis. J Cosmet Dermatol. 2023;22(4):1168-1176. doi:10.1111/jocd.15566 https://pubmed.ncbi.nlm.nih.gov/36566490/
[6] Rajaratnam R, Halpern J, Salim A, Emmett C. Interventions for melasma. Cochrane Database Syst Rev. 2010;2010(7):CD003583. doi:10.1002/14651858.cd003583.pub2 https://pubmed.ncbi.nlm.nih.gov/20614435/
[7] American Academy of Dermatology. What to look for: ABCDEs of melanoma. https://www.aad.org/public/diseases/skin-cancer/find/at-risk/abcdes